SNCA and Parkinson disease: Evidence presented by van der Goot et al. [22] suggests that the protection of tdo-2 knockdown against pathology in a C. elegans model of alpha-synuclein proteotoxicity (modeling Parkinson’s disease) may be mediated by elevated physiological levels of tryptophan.